We create bacterial therapies of the human skin and mucosal microbiome against pathogenic bacteria. Our first suite of products (NASOFLORE line) targets Staphyloccocus aureus / MRSA (Methicillin resistant S aureus). The products based on live bacteria identified in our clinical and in vitro studies do not generate emergence of antibiotic resistance.
Company Details
- Founded
- 2020
- Address
- Paris, Fr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- diotheris.com
- HQ
- Paris
Diotheris Questions
Diotheris's website is diotheris.com
Diotheris's LinkedIn profile is https://fr.linkedin.com/company/diotheris
Diotheris's industry is
Biotechnology Research
Diotheris's top competitors are
Yphen Sas,
Aelis Farma,
Fungimaker,
Myceen,
Vibiosphen,
Pili,
The Serious Gut,
Ysopia Bioscience,
Neurophoenix,
Sweetech.
Diotheris's categories are Biotechnology Research
Diotheris's founding year is 2020
